Revenue

As Xerox prepares its Q2 report, all eyes are on its digital reinvention. Can the legacy giant prove its IT and AI strategy is paying off?

As OmniAb preps its Q2 results, the real story isn't just the numbers. It's the 'Biological Intelligence' platform reshaping drug discovery from the ground up.

As Black Rock Coffee Bar opens its 58th Phoenix location, a deeper look reveals a strategy built not just on beans, but on a radical culture-first model.

With its MASH drug Rezdiffra a certified blockbuster, Madrigal's upcoming Q2 report will reveal if its meteoric rise can be sustained against new rivals.

A new marketing deal between Planet Green and iFLYTEK is more than a contract; it's a story of survival, strategy, and geopolitical risk in tech.

With its first major acquisition and a new VP of Growth, specialty ink firm Nocopi Technologies is executing a deliberate strategy to scale its operations.

The workforce giant's Q2 results reveal a masterclass in strategic execution, leveraging AI and smart divestitures to engineer a major comeback.

The UK SME lender reports a 50% revenue jump and soaring profits, crediting its AI platform and new FlexiPay and Card products for defying market headwinds.

As investors await Multitude AG’s mid-year results, a look at recent performance and a shifting European regulatory landscape reveals a story of strategic recalibration.

With a $70M Series C and unique 3D printing tech, SWISSto12 proves the new space economy is moving beyond hype to sustainable, profitable infrastructure.

With profits rebounding and a major acquisition secured, GTPL Hathway's Q1 results signal a bold new phase of strategic expansion and technological ambition.

The cord blood pioneer reported a 56% profit surge despite a revenue dip. But a key dispute with Duke University has halted its ambitious expansion into therapy.

Despite currency headwinds, Karooooo posted record subscriber growth. Our analysis unpacks the operational strategy turning investment into market dominance.

As EverQuote prepares its Q2 2026 report, the market watches closely. Will its AI-powered growth engine justify its ambitious vision for the P&C sector?

As Applied Digital prepares its year-end report, all eyes are on the data center builder. Can it sustain its explosive growth and justify its massive bets on AI?

The firm reported a Q4 loss but a record $111M backlog fuels its ambitious plan for $150M revenue and a pivot to high-growth quantum and defense markets.

Parse Biosciences, QIAGEN's strategic acquisition, just partnered with Australia's Garvan Institute. It's more than science—it's a calculated play to win.

Once a nanotech firm, then a supplement seller, Bioforce Nanosciences is now an oil explorer. Its new 20,000-acre Nevada lease is a high-stakes gamble to reverse a history of financial peril.

Plumas Bancorp's record earnings are fueled by a major acquisition, but a spike in nonperforming assets reveals the inherent risks of rapid expansion.